148 related articles for article (PubMed ID: 25208979)
21. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.
Cammà C; Schepis F; Orlando A; Albanese M; Shahied L; Trevisani F; Andreone P; Craxì A; Cottone M
Radiology; 2002 Jul; 224(1):47-54. PubMed ID: 12091661
[TBL] [Abstract][Full Text] [Related]
22. Preoperative transarterial chemoembolization and resection for hepatocellular carcinoma: a nationwide Taiwan database analysis of long-term outcome predictors.
Shi HY; Wang SN; Wang SC; Chuang SC; Chen CM; Lee KT
J Surg Oncol; 2014 Apr; 109(5):487-93. PubMed ID: 24293372
[TBL] [Abstract][Full Text] [Related]
23. A randomized controlled trial of transcatheter arterial chemoembolization with lipiodol, doxorubicin and cisplatin versus intravenous doxorubicin for patients with unresectable hepatocellular carcinoma.
Mabed M; Esmaeel M; El-Khodary T; Awad M; Amer T
Eur J Cancer Care (Engl); 2009 Sep; 18(5):492-9. PubMed ID: 19453695
[TBL] [Abstract][Full Text] [Related]
24. Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial.
Kudo M; Han G; Finn RS; Poon RT; Blanc JF; Yan L; Yang J; Lu L; Tak WY; Yu X; Lee JH; Lin SM; Wu C; Tanwandee T; Shao G; Walters IB; Dela Cruz C; Poulart V; Wang JH
Hepatology; 2014 Nov; 60(5):1697-707. PubMed ID: 24996197
[TBL] [Abstract][Full Text] [Related]
25. Postoperative transhepatic arterial chemoembolization and portal vein chemotherapy for patients with hepatocellular carcinoma: a randomized study with 131 cases.
Li Q; Wang J; Sun Y; Cui YL; Juzi JT; Qian BY; Hao XS
Dig Surg; 2006; 23(4):235-40. PubMed ID: 16943671
[TBL] [Abstract][Full Text] [Related]
26. Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels.
Huang G; Lai EC; Lau WY; Zhou WP; Shen F; Pan ZY; Fu SY; Wu MC
Ann Surg; 2013 Mar; 257(3):490-505. PubMed ID: 22868358
[TBL] [Abstract][Full Text] [Related]
27. Liver transplantation versus liver resection in the treatment of hepatocellular carcinoma: a meta-analysis of observational studies.
Zheng Z; Liang W; Milgrom DP; Zheng Z; Schroder PM; Kong NS; Yang C; Guo Z; He X
Transplantation; 2014 Jan; 97(2):227-34. PubMed ID: 24142034
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant chemolipiodolization reduces early recurrence derived from intrahepatic metastasis of hepatocellular carcinoma after hepatectomy.
Ueno M; Uchiyama K; Ozawa S; Hayami S; Shigekawa Y; Tani M; Yamaue H
Ann Surg Oncol; 2011 Dec; 18(13):3624-31. PubMed ID: 21614626
[TBL] [Abstract][Full Text] [Related]
29. Comparison of survival and quality of life of hepatectomy and thrombectomy using total hepatic vascular exclusion and chemotherapy alone in patients with hepatocellular carcinoma and tumor thrombi in the inferior vena cava and hepatic vein.
Liu J; Wang Y; Zhang D; Liu B; Ou Q
Eur J Gastroenterol Hepatol; 2012 Feb; 24(2):186-94. PubMed ID: 22081008
[TBL] [Abstract][Full Text] [Related]
30. Changing trends in long-term outcomes after hepatic resection for hepatocellular carcinoma: A 30-year, single-center experience.
Yamamoto Y; Ikoma H; Morimura R; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
Anticancer Res; 2013 Nov; 33(11):5097-105. PubMed ID: 24222155
[TBL] [Abstract][Full Text] [Related]
31. Doxorubicin-eluting beads versus conventional transarterial chemoembolization for the treatment of hepatocellular carcinoma.
Huang K; Zhou Q; Wang R; Cheng D; Ma Y
J Gastroenterol Hepatol; 2014 May; 29(5):920-5. PubMed ID: 24224722
[TBL] [Abstract][Full Text] [Related]
32. A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma.
Cabibbo G; Enea M; Attanasio M; Bruix J; Craxì A; Cammà C
Hepatology; 2010 Apr; 51(4):1274-83. PubMed ID: 20112254
[TBL] [Abstract][Full Text] [Related]
33. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
Zhao M; Wang JP; Li W; Huang ZL; Zhang FJ; Fan WJ; Zhang L; Li XS; Pan CC; Wu PH
Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1167-72. PubMed ID: 21756768
[TBL] [Abstract][Full Text] [Related]
34. Effect of adjuvant interferon therapy on hepatitis b/c virus-related hepatocellular carcinoma after curative therapy - meta-analysis.
Xu J; Li J; Chen J; Liu ZJ
Adv Clin Exp Med; 2015; 24(2):331-40. PubMed ID: 25931368
[TBL] [Abstract][Full Text] [Related]
35. Optimal adjuvant therapy for resected hepatocellular carcinoma: a systematic review with network meta-analysis.
Zhu GQ; Shi KQ; Yu HJ; He SY; Braddock M; Zhou MT; Chen YP; Zheng MH
Oncotarget; 2015 Jul; 6(20):18151-61. PubMed ID: 26061709
[TBL] [Abstract][Full Text] [Related]
36. Comparative survival analysis of adjuvant therapy with iodine-131-labeled lipiodol to hepatic resection of primary hepatocellular carcinoma: a meta-analysis.
Gong L; Shi L; Sun J; Yuan WS; Chen JF; Liu P; Gong F; Dong JH
Nucl Med Commun; 2014 May; 35(5):484-92. PubMed ID: 24492679
[TBL] [Abstract][Full Text] [Related]
37. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis.
Wang W; Shi J; Xie WF
Liver Int; 2010 May; 30(5):741-9. PubMed ID: 20331507
[TBL] [Abstract][Full Text] [Related]
38. [The value of portal vein chemotherapy after radical resection in delaying intrahepatic recurrence of stage II primary hepatocellular carcinoma].
Zhang GQ; Ge L; Ding W; Li HJ
Ai Zheng; 2008 Dec; 27(12):1297-301. PubMed ID: 19079997
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of transarterial chemoembolization targeting portal vein tumor thrombus in patients with hepatocellular carcinoma.
Tawada A; Chiba T; Ooka Y; Kanogawa N; Motoyama T; Saito T; Ogasawara S; Suzuki E; Maruyama H; Kanai F; Yoshikawa M; Yokosuka O
Anticancer Res; 2014 Aug; 34(8):4231-7. PubMed ID: 25075052
[TBL] [Abstract][Full Text] [Related]
40. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion.
Kim KM; Kim JH; Park IS; Ko GY; Yoon HK; Sung KB; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
J Gastroenterol Hepatol; 2009 May; 24(5):806-14. PubMed ID: 19207681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
